The news on Ozempic (semaglutide) injection for Type 2 Diabetes
ShareThere has been 172 news on Ozempic (semaglutide) injection for Type 2 Diabetes in the past from 37 different sources and amongst 7 sections.
Full access to all news in this scope:
See the trend on this scope:
Evolution through time
Latest news
Healthy Returns: Ozempic helps curb alcohol use in new study -- and doctors are concerned about telehealth GLP-1s
Strongest evidence yet that Ozempic and Wegovy reduce alcohol intake
Novo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy
Ozempic has curbed the obesity crisis. Has it killed the joy of food?
Trump's Medicaid freeze, Ozempic for kidney disease, and 23andMe for sale: Pharma news roundup
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Wegovy and Ozempic top list of 15 drugs up for next price negotiations
Ozempic, Wegovy top list of Biden's price-negotiation drugs
Ozempic and Wegovy have heart health benefits beyond just weight loss
We'll learn about Ozempic's potential for Alzheimer's disease in 2025
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Sections
The coverage spreads amongst 7 sections:
Sources
There has been 37 news sources reporting on this, including: Quartz (30%), NBC News (6%), CNBC News (6%), The Hill (5%), The New York Times (4%).
Going further
Stay up to date:
Details
This content can be used under the CC BY 4.0 license
